Five Prime Therapeutics (FPRX) PT Lowered to $60 at BMO Capital Feb 28, 2018 03:51AM
Five Prime Therapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference Dec 4, 2017 04:05PM
Five Prime Therapeutics (FPRX): Buy on Weakness - BMO Nov 13, 2017 06:40AM
Pre-Open Stock Movers 10/16: (TRXC) (RT) (EXEL) Higher; (AMPE) (ADBE) (ISRG) Lower (more...) Oct 16, 2017 09:32AM
BMO Capital Upgrades Five Prime Therapeutics (FPRX) to Outperform Oct 16, 2017 03:13AM


Apr 11, 2016 04:15PM BMO Capital Starts Five Prime Therapeutics (FPRX) at Market Perform
Mar 18, 2015 08:26AM Five Prime Therapeutics (FPRX) PT Raised to $31 at BMO Capital
Nov 24, 2014 01:27PM Five Prime Therapeutics' (FPRX) Bristol-Myers Collaboration Validates Thesis, BMO Capital Says
Feb 12, 2014 04:05PM Five Prime Therapeutics Announces Closing of Public Offering
Feb 10, 2014 09:15AM Five Prime Announces the Full Exercise of the Underwriters' Option to Purchase Additional Shares
Feb 6, 2014 11:18PM Five Prime Therapeutics Prices Public Offering of Common Stock
Oct 14, 2013 08:48AM BMO Capital Starts Five Prime Therapeutics (FPRX) at Outperform
Sep 18, 2013 12:02PM Clinical-Stage Biotech IPO for Five Prime Therapeutics (FPRX) Opens Higher